---
schema_version: "secwatch.filing_event.v1"
accession: "0001558370-23-000715"
form_type: "8-K"
ticker: "TECH"
cik: "0000842023"
company_name: "BIO-TECHNE Corp"
filed_at: "2023-01-31T23:59:59+00:00"
generated_at: "2026-06-20T06:06:33.546914+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Bio-Techne appoints Shane Bohnen as SVP, General Counsel; Brenda Furlow retires March 3, 2023

## Summary
- Shane Bohnen, previously Associate General Counsel since 2019, becomes Senior VP, General Counsel effective March 3, 2023.
- Brenda Furlow, EVP & General Counsel for nine years, retires March 3, 2023; will remain as consultant for special projects.
- Bohnen's compensation: $331,500 base salary, 50% target cash bonus, one-time $500,000 RSU grant vesting over three years.
- Bohnen has over 20 years legal experience including private practice and in-house at Smiths Medical and Resideo.

## SEC filing metadata
- accession: 0001558370-23-000715
- form_type: 8-K
- ticker: TECH
- cik: 0000842023
- company_name: BIO-TECHNE Corp
- filed_at: 2023-01-31T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/842023/000155837023000715/0001558370-23-000715-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/842023/000155837023000715/tmb-20230126x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001558370-23-000715
- JSON: https://secwatch.observer/filing/0001558370-23-000715.json
- Plain text: https://secwatch.observer/filing/0001558370-23-000715.txt

## Key facts
- Executive change
  Brenda Furlow retired as general_counsel at BIO-TECHNE Corp.
  - Action: retired
  source text: Mr. Bohnen succeeds Brenda Furlow, who has announced her intention to retire on March 3, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/842023/000155837023000715/0001558370-23-000715-index.htm
- Executive change
  Shane Bohnen was appointed as Senior Vice President, General Counsel and Corporate Secretary at BIO-TECHNE Corp.
  - Action: appointed
  - Role: Senior Vice President, General Counsel and Corporate Secretary
  source text: appointed Mr. Shane Bohnen, age 48, as an executive officer of the Company in the position of Senior Vice President, General Counsel and Corporate Secretary, effective March 3, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/842023/000155837023000715/0001558370-23-000715-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.